Global Healthcare Regulatory Affairs Outsourcing Market

 

Manufacturing and controls (CMC), medial report writing, regulatory chemistry, data management, country regulatory affairs, regulatory strategy, and labelling and liaison are just a few of the processes that are regulated. Healthcare organisations can focus on marketing and research and development by outsourcing these non-core activities to experts. Product approvals, optimised reimbursements, and increased productivity can all benefit businesses in the long run.

 

Drivers: In addition, the rising prevalence of several chronic diseases, such as cancer and other infectious diseases, has prompted biopharmaceutical companies to develop a slew of new products. As the number of products in clinical trials grows, so does the demand for clinical trial applications and product registration services, propelling this market forward.

 

Healthcare Regulatory Affairs Outsourcing Market

 

                                         

                                              Know more about this report: request for sample pages

 

Restraints: Life sciences companies are under a lot of pressure to cut costs. Market growth is expected to be hampered in the forecasting period due to a loss of control and technological advancements leading to price fluctuations.

 

Impact of Covid-19

 

The COVID-19 pandemic has caused delays in drug development, manufacturing, supply chain, and almost all other aspects of the process. Furthermore, market participants face particular challenges such as tight deadlines and round-the-clock staff availability. However, the clinical trial service segment is growing due to a large number of ongoing clinical trials in response to the COVID-19 pandemic. Communication with regulatory bodies has become unpredictably unpredictable, with long wait times for responses from review teams or agencies that are critical to moving the development process forward. Furthermore, market participants must contend with time constraints and personnel availability 24 hours a day, seven days a week.

 

Segmentation By Service: Global Healthcare Regulatory Affairs Outsourcing Market is classified on the basis of Service into Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, and Other Services.

 

Segmentation By Company Size: Global Healthcare Regulatory Affairs Outsourcing Market is classified on the basis of Company Size into Small, Medium, and Large.

 

Segmentation By Stage: Global Healthcare Regulatory Affairs Outsourcing Market is classified on the basis of Stage into Preclinical, Clinical, and PMA (Post Market Authorization).

 

Segmentation By End-User: Global Healthcare Regulatory Affairs Outsourcing Market is classified on the basis of End-User into Medical Device Companies, Pharmaceutical Companies, and Biotechnology Companies.

 

Segmentation By Region: Global Healthcare Regulatory Affairs Outsourcing Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

 

Competitive Landscape: The key players of Global Healthcare Regulatory Affairs Outsourcing Market  are Covance Inc, Cardinal Health, Paraxel and Kyoto University Hospital, IQVIA, KLIFO, ProPharma Group, Arriello Ireland Ltd., DRA CONSULTING OY, and Asphalion S.L.

 

Industrial Development

 

  • In April of this year, Cardinal Health acquired mscripts. This acquisition will enhance the company's capabilities for customers while also strengthening the relationship between payers, pharmacies, and patients.
  • In October 2021, Paraxel and Kyoto University Hospital announced a strategic partnership aimed at expanding clinical research opportunities and improving clinical study support.
  • IQVIA announced in April 2021 that it had acquired a minority stake in Q2 Solutions, a central laboratory services joint venture, from Quest Diagnostics.

 

Market Taxonomy

 

By Service

 

  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing & Publishing
  • Product Registration & Clinical Trial Applications
  • Other Services

 

By Company Size

 

  • Small
  • Medium
  • Large

 

By Stage

 

  • Preclinical
  • Clinical
  • PMA (Post Market Authorization)

 

By End-user

 

  • Medical Device Companies
  • Pharmaceutical Companies
  • Biotechnology Companies

 

By Region

 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

 

Key Questions Addressed by the Report

 

  • What are the Key Opportunities in Global Healthcare Regulatory Affairs Outsourcing Market?
  • What will be the growth rate from 2020 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?

Healthcare Regulatory Affairs Outsourcing Market TOC

 

1 Introduction

       
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope

 

2 Research Methodology

 

2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources

 

3 Executive Summary


4 Global Healthcare Regulatory Affairs Outsourcing  Market Outlook


4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

 

5. Global Healthcare Regulatory Affairs Outsourcing Market, By Service


5.1 Y-o-Y Growth Comparison, By Service
5.2 Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Service
5.3 Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Service
5.3.1 Regulatory Consulting

5.3.2 Legal Representation

5.3.3 Regulatory Writing & Publishing

5.3.4 Product Registration & Clinical Trial Company Sizes

5.3.5 Other Services

 

6. Global Healthcare Regulatory Affairs Outsourcing Market, By Company Size

 

6.1 Y-o-Y Growth Comparison, By Company Size

6.2 Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Company Size

6.3 Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Company Size

6.3.1 Small

6.3.2 Medium

6.3.3 Large

 

7. Global Healthcare Regulatory Affairs Outsourcing Market, By Stage

 

7.1 Y-o-Y Growth Comparison, By Stage

7.2 Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Stage

7.3 Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Stage

7.3.1 Preclinical

7.3.2 Clinical

7.3.3 PMA (Post Market Authorization)

 

8. Global Healthcare Regulatory Affairs Outsourcing Market, By End-User

 

8.1 Y-o-Y Growth Comparison, By End-User

8. Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By End-User

8.3 Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By End-User

8.3.1 Medical Device Companies

8.3.2 Pharmaceutical Companies

8.3.3 Biotechnology Companies

 

9. Global Healthcare Regulatory Affairs Outsourcing Market, By Region

 

9.1 Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Region

9.2 Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Region

9.3 Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Region

 

10. North America Healthcare Regulatory Affairs Outsourcing Analysis and Forecast (2021-2027)

 

10.1 Introduction

10.2 North America Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Service

10.3 North America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Company Size

10.4 North America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Stage

10.5 North America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By End-User

10.6 North America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Country

10.6.1 US

10.6.2 Canada

 

11. Europe Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast (2021-2027)

 

11.1 Introduction

11.2 Europe Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Service

11.3 Europe Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Company Size

11.4 Europe Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Stage

11.5 Europe Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By End-User

11.6 Europe Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Country

11.6.1 UK

11.6.2 Germany

11.6.3 France

11.6.4 Italy

11.6.5 Spain

11.6.6 Netherland

 

12. Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast (2021-2027)

 

12.1 Introduction

12.2 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Service

12.3 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Company Size

12.4 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Stage

12.5 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By End-User

12.6 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Country

12.6.1 China

12.6.2 Japan

12.6.3 India

12.6.4 Australia

 

13. Latin America Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast (2021-2027)

 

13.1 Introduction

13.2 Latin America Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Service

13.3 Latin America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Company Size

13.4 Latin America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Stage

13.5 Latin America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By End-User

13.6 Latin America Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Country

13.6.1 Brazil

13.6.2 Rest of Latin America

 

14 Middle East Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast (2021-2027)


14.1 Introduction

14.2 Middle East Healthcare Regulatory Affairs Outsourcing Market Share Analysis, By Service

14.3 Middle East Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Company Size

14.4 Middle East Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Stage

14.5 Middle East Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By End-User

14.6 Middle East Healthcare Regulatory Affairs Outsourcing Market Size and Forecast, By Country

14.6.1 Saudi Arabia

14.6.2 UAE

14.6.3. Egypt

14.6.4. Kuwait

14.6.5. South Africa

 

15 Competitive Analysis

 

15.1 Competition Dashboard

15.2 Market share Analysis of Top Vendors

15.3 Key Development Strategies

 

16. Company Profiles

 

16.1 Covance Inc

 

16.1.1 Overview

16.1.2 Offerings

16.1.3 Key Financials

16.1.4 Business Segment & Geographic Overview

16.1.5 Key Market Developments

16.1.6 Key Strategies

 

16.2 Cardinal Health

 

16.2.1 Overview

16.2.2 Offerings

16.2.3 Key Financials

16.2.4 Business Segment & Geographic Overview

16.2.5 Key Market Developments

16.2.6 Key Strategies

 

16.3 Paraxel and Kyoto University Hospital

 

16.3.1 Overview

16.3.2 Offerings

16.3.3 Key Financials

16.3.4 Business Segment & Geographic Overview

16.3.5 Key Market Developments

16.3.6 Key Strategies

 

16.4 IQVIA

 

16.4.1 Overview

16.4.2 Offerings

16.4.3 Key Financials

16.4.4 Business Segment & Geographic Overview

16.4.5 Key Market Developments

16.4.6 Key Strategies

 

16.5 KLIFO

 

16.5.1 Overview

16.5.2 Offerings

16.5.3 Key Financials

16.5.4 Business Segment & Geographic Overview

16.5.5 Key Market Developments

16.5.6 Key Strategies

 

16.6 ProPharma Group

 

16.6.1 Overview

16.6.2 Offerings

16.6.3 Key Financials

16.6.4 Business Segment & Geographic Overview

16.6.5 Key Market Developments

16.6.6 Key Strategies

 

16.7 Arriello Ireland Ltd

 

16.7.1 Overview

16.7.2 Offerings

16.7.3 Key Financials

16.7.4 Business Segment & Geographic Overview

16.7.5 Key Market Developments

16.7.6 Key Strategies

 

16.8 DRA CONSULTING OY

 

16.8.1 Overview

16.8.2 Offerings

16.8.3 Key Financials

16.8.4 Business Segment & Geographic Overview

16.8.5 Key Market Developments

16.8.6 Key Strategies

 

16.9 Asphalion S.L

 

16.9.1 Overview

16.9.2 Offerings

16.9.3 Key Financials

16.9.4 Business Segment & Geographic Overview

16.9.5 Key Market Developments

16.9.6 Key Strategies